CD86 and B-cell neoplasm: The effective communication between two subsets of co-stimulatory molecules of neoplastic B cells, CD80 (B7.1) and CD86 (B7.2), and the CD28 or cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) of T cells, is thought to play important roles in the tumorigenesis of B cell neoplasms [36,37,38].